Emerging molecular markers of cancer.
Alterations in gene sequences, expression levels and protein structure or function have been associated with every type of cancer. These 'molecular markers' can be useful in detecting cancer, determining prognosis and monitoring disease progression or therapeutic response. But what is the best way to identify molecular markers and can they be easily incorporated into the clinical setting?
Sidransky
David
D
The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. dsidrans@jhmi.edu
D004247:DNA / Q000097:blood; D005819:Genetic Markers; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D012680:Sensitivity and Specificity
D005819:Genetic Markers; D004247:DNA